Showing results (101-110 of 115) with videos related to

Sort By:
Pageof 12
Conflict and Health|February 5, 2025
Realising health justice in Palestine: beyond humanitarian voicesJames Smith, Sara El-Solh, Layth Hanbali, et al.
ESMO Open|July 16, 2020
Buparlisib plus carboplatin or lomustine in patients with recurrent glioblastoma: a phase Ib/II, open-label, multicentre, randomised studyMark Rosenthal, Paul M Clement, Mario Campone, et al.
Photoacoustics|July 2, 2026
An intelligent point-of-care photoacoustic and ultrasound dual-modality imaging system for Rheumatoid arthritis in fingers: Technical development and initial clinical testXiaorui Peng, Kyoungmo Koo, Jianwei Qiu, et al.
Neurology|July 21, 2023
Microstructural Alterations in Tract Development in College Football and Volleyball Players: A Longitudinal Diffusion MRI StudyMaged Goubran, Brian David Mills, Marios Georgiadis, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 29, 2014
Phase Ib study of Buparlisib plus Trastuzumab in patients with HER2-positive advanced or metastatic breast cancer that has progressed on Trastuzumab-based therapyCristina Saura, Johanna Bendell, Guy Jerusalem, et al.
Conflict and Health|February 24, 2026
Hospital functionality in the Gaza Strip: analysis of the World Health Organization health resources and services availability monitoring system database, 7 Oct 2023 to 31 Oct 2024David Mills, Yara Asi, Dennis Kunichoff, et al.
Research Square|April 16, 2025
Gut Microbiota Protects Against Liver Injury and Fibrosis via Activation of the CYP Eicosanoid PathwayGuodong Zhang, Quancai Sun, Jing Sun, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 27, 2010
Genome analysis of Bifidobacterium bifidum PRL2010 reveals metabolic pathways for host-derived glycan foragingFrancesca Turroni, Francesca Bottacini, Elena Foroni, et al.
Molecular Cancer Therapeutics|August 22, 2024
Preclinical Characterization of ARX517, a Site-Specific Stable PSMA-Targeted Antibody-Drug Conjugate for the Treatment of Metastatic Castration-Resistant Prostate CancerLillian K Skidmore, David Mills, Ji Young Kim, et al.
The New England Journal of Medicine|May 16, 2019
Alpelisib for <i>PIK3CA</i>-Mutated, Hormone Receptor-Positive Advanced Breast CancerFabrice André, Eva Ciruelos, Gabor Rubovszky, et al.
Pageof 12